Literature DB >> 10604558

Experimental common cold increases mucosal output of eotaxin in atopic individuals.

L Greiff1, M Andersson, E Andersson, M Linden, S Myint, C Svensson, C G Persson.   

Abstract

BACKGROUND: In view of recent observations demonstrating that rhinovirus infections are associated with increased local activity of eosinophils, we hypothesized that eotaxin, a selective eosinophil chemoattractant, may be involved in eosinophil recruitment/activation in common cold infections.
METHODS: Twenty-three patients with seasonal allergic rhinitis were inoculated with human rhinovirus 16 (HRV 16) outside the pollen season. Sequential diluent and allergen (10(3) SQ-U) challenges, each followed by nasal lavage, were carried out about 3 months before and 4 days after virus inoculation.
RESULTS: Seventeen patients developed common cold and were further analyzed. Lavage fluid levels of eotaxin were increased at the height of active common cold (day 4 after inoculation) both at baseline (after diluent challenge) (P<0.01) and acutely after allergen challenge (P<0.05).
CONCLUSIONS: Common cold symptoms after nasal HRV 16 inoculation are associated with increased nasal mucosal output of eotaxin, suggesting that this chemokine is partly responsible for recruitment/activation of airway mucosal eosinophils in common cold infections.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10604558     DOI: 10.1034/j.1398-9995.1999.00172.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  5 in total

1.  Effects of a dual CCR3 and H1-antagonist on symptoms and eosinophilic inflammation in allergic rhinitis.

Authors:  Lennart Greiff; Cecilia Ahlström-Emanuelsson; Ash Bahl; Thomas Bengtsson; Kerstin Dahlström; Jonas Erjefält; Henrik Widegren; Morgan Andersson
Journal:  Respir Res       Date:  2010-02-09

Review 2.  Rhinoviruses in the pathogenesis of asthma.

Authors:  Nikolaos G Papadopoulos; Stelios Psarras
Journal:  Curr Allergy Asthma Rep       Date:  2003-03       Impact factor: 4.919

Review 3.  Utility of animal and in vivo experimental infection of humans with rhinoviruses in the development of therapeutic agents for viral exacerbations of asthma and chronic obstructive pulmonary disease.

Authors:  Alfred M Del Vecchio; Patrick J Branigan; Elliot S Barnathan; Susan K Flavin; Philip E Silkoff; Ronald B Turner
Journal:  Pulm Pharmacol Ther       Date:  2014-11-13       Impact factor: 3.410

Review 4.  Mechanisms of virus-induced asthma exacerbations: state-of-the-art. A GA2LEN and InterAirways document.

Authors:  N G Papadopoulos; P Xepapadaki; P Mallia; G Brusselle; J-B Watelet; M Xatzipsalti; G Foteinos; C M van Drunen; W J Fokkens; C D'Ambrosio; S Bonini; A Bossios; Jan Lötvall; P van Cauwenberge; S T Holgate; G W Canonica; A Szczeklik; G Rohde; J Kimpen; A Pitkäranta; M Mäkelä; P Chanez; J Ring; S L Johnston
Journal:  Allergy       Date:  2007-02-27       Impact factor: 13.146

Review 5.  Host defense function of the airway epithelium in health and disease: clinical background.

Authors:  Simon D Message; Sebastian L Johnston
Journal:  J Leukoc Biol       Date:  2003-09-12       Impact factor: 4.962

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.